From: Using arterial-venous oxygen difference to guide red blood cell transfusion strategy
Variables | Unadjusted odds ratio | p value | Adjusted odds ratio | p value |
---|---|---|---|---|
Age, years | 1.02 [0.98–1.03] | 0.85 | ||
BMI, kg/m2 | 1.09 [0.99–1.20] | 0.73 | ||
SAPS II | 1.02 [1.00–1.05] | 0.05 | 1.01 [0.99–1.04] | 0.39 |
Transfused, n (%) | 0.93 [0.49–1.74] | 0.83 | ||
“Appropriate” group | 0.39 [0.21–0.75] | 0.004 | 0.48 [0.25–0.92] | 0.03 |
SOFA score | 1.07 [0.95–1.22] | 0.26 | ||
Comorbidity | ||||
Heart disease, n (%) | 1.17 [0.56–2.42] | 0.57 | ||
Hypertension, n (%) | 1.18 [0.55–2.55] | 0.67 | ||
Diabetes, n (%) | 1.74 [0.81–3.75] | 0.16 | ||
COPD/asthma, n (%) | 0.61 [0.23–1.65] | 0.33 | ||
History of smoking, n (%) | 1.02 [0.57–2.52] | 0.98 | ||
Chronic renal disease, n (%) | 1.10 [0.49–2.44] | 0.81 | ||
Laboratory values on inclusion | ||||
Hemoglobin, g/dL | 1.16 [0.74–1.81] | 0.51 | ||
Platelets, 103/μL | 0.99 [0.99–1.01] | 0.20 | ||
INR | 1.57 [0.42–5.79] | 0.49 | ||
RDW, % | 1.12 [1.01–1.25] | 0.04 | 1.11 [0.99–1.24] | 0.07 |
Creatinine, mg/dL | 1.03 [0.92–1.29] | 0.68 | ||
Bilirubin, mg/dL | 1.35 [0.84–2.18] | 0.21 | ||
Lactate, mmol/L | 1.36 [1.04–1.78] | 0.02 | 1.22 [0.95–1.59] | 0.12 |
PaO2/FiO2 ratio | 0.99 [0.99–1.13] | 0.62 |